Nbetherapeutics
NBE-Therapeutics is a Swiss biotech company that was founded in 2012 and acquired by Boehringer Ingelheim in December 2020. The company focuses on developing immune-stimulatory therapies for cancer treatment using its proprietary Antibody-Drug Conjugate platform. NBE-Therapeutics aims to improve the quality of life and increase survival rates for cancer patients worldwide....
N/A
Technology
N/A
Founded
N/A
Employees
Advanced and Next Generation Therapies (Various)
Industry
Visual (Placeholder)
Profile Information
Name
Nbetherapeutics
Industry
Advanced and Next Generation Therapies (Various)
Technology
N/A
Location
N/A
Founded
N/A
Employees
N/A
Category
Companies
Contact Information
Website
Email
RESNBEInfo.BAS@boehringer-ingelheim.com
Phone
N/A
Address
N/A